Dr. Labiento Smith controls early myopia progression with low-dose Atropine and/or Orthokeratology. She bases her treatment on the current literature and recent LAMP study. These treatments for myopia control are considered an off-label use in the United States.. The medication Atropine and Ortho-K are FDA approved but under a different category and use. All children with active myopia progression at Sudbury Eye Care are seen bi-annually for exams to monitor progression.
I visited Sudbury Eye Care for the first time this morning and had a fantastic experience. There was trouble with my insurance company and Sudbury Eye Care took the liberty to contact the company directly and make sure everything was correct. Dr. Labiento Smith has a great practice and I highly reccomend to anyone looking for an Eye Care Professional. It’s always nice to stay/support a local business and even better when you receive great service!
Patrick J. — Yelp